Cardiovascular risk reduction with integrated care: results of 8 years follow up
Tóm tắt
Care groups organize integrated cardiovascular risk management programs in primary care for high risk patients. Results of long term cardiovascular risk management are scarce. The aim was to describe changes in low density lipoprotein cholesterol, systolic blood pressure and smoking between 2011 and 2018 in patients participating in an integrated program for cardiovascular risk management organized by a care group in the Netherlands. To explore whether long-term participation in an integrated cardiovascular risk management program could lead to the improvement of 3 important risk factors for cardiovascular disease. A protocol was developed for delegated practice nurse activities. A multidisciplinary data registry was used for uniform registration. The care group organized annual education for general practitioners and practice nurses on cardiovascular topics and regular meetings for practice nurses only to discuss complex patient cases and implementation issues. From 2015 onwards, the care group started with practice visitations to discuss performance and support practices with organizing integrated care. In patients eligible for primary prevention as well as for secondary prevention similar trends were observed: lipid modifying and blood pressure lowering medication increased, mean low density lipoprotein cholesterol and mean systolic blood pressure decreased, patients on target for low density lipoprotein cholesterol and systolic blood pressure increased and the proportion of non-smokers with both low density lipoprotein cholesterol and systolic blood pressure on target increased. Improved registration between 2011 and 2013 was partly responsible for the sharp increase of patients on target for low density lipoprotein cholesterol and systolic blood pressure. In patients participating in an integrated cardiovascular risk management program, we saw annual improvements in 3 important cardiovascular risk factors between 2011 and 2018.
Tài liệu tham khảo
Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, Burns R, Rayner M, Townsend N. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network; 2017.
Schweikert B, Hunger M, Meisinger C, Gapp O, Holle R. Quality of life several years after myocardial infarction: comparing the MONIKA/KORA registry tot he general population. Eur Heart J. 2009;30(4):436–43. https://doi.org/10.1093/eurheartj/ehn509.
Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MSV. Quality of life declines after first ischemic stroke The Northern Manhattan Study. Neurology. 2010;75(4):328–34.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet. 2004;364:937–52. https://doi.org/10.1016/S0140-6736(04)17018-9.
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S; INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–75. https://doi.org/10.1016/S0140-6736(16)30506-2.
Smulders YM, Burgers JS, Scheltens T, van Hout BA, Wiersma T, Simoons ML. Guideline development group for the Dutch guideline for multidisciplinary cardiovascular risk management. Clinical practice guideline for cardiovascular risk management in the Netherlands. Neth J Med. 2008;66(4):169–74 Review. PubMed PMID: 18424866.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixt Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EAPCR). Eur Heart J. 2016;37(29):2315–81.
Drenthen AJM, Assendelft WJJ, Van der Velden J. Prevention in the general practice: get moving! Huisarts Wet. 2008;51(1):38–41.
Laurant M, Harmsen M, Wollersheim H, et al. The impact of non-physician clinicians. Do they improve the quality and cost-effectiveness of health care services? Med Care Res Rev. 2009;66(6 Suppl):36S-89S.
Voogdt-Pruis HR, Beusmans GH, Gorgels AP, Kester A, Van Ree JW. Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. Br J Gen Pract. 2010;60(570):40–6. https://doi.org/10.3399/bjgp10X482095.
Kotseva K, De Bacquer D, De Backer G, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the european society of cardiology european action on secondary and primary prevention by intervention to reduce events (EUROASPIRE) IV cross-sectional survey in 14 european regions. Eur J Prev Cardiol. 2016;23(18):2007–18.
Kotseva K, De Backer G, De Bacquer D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the european society of cardiology EURObservational research programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2021;28(4):370–9. https://doi.org/10.1177/2047487320908698. Epub 2020 Mar 20.
Grol R. Successes and Failures in the Implementation of Evidence-Based Guidelines for Clinical Practice. Med CARE. 2001;39(8 Supplement 2):II-46–II-54.
Grimshaw J, Russel IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317–22.
v Til JT, de Wildt JE, Struis JN. De organisatie van zorggroepen anno 2010. Huidige stand van zaken en de ontwikkelingen in de afgelopen jaren. RIVM rapport 260332001/2010 www.
Smits GH, Van Doorn S, Bots ML, Hollander M. Stepwise implementation of a cardiovascular risk management program in primary care. BMC Fam Pract. 2022;23:1. https://doi.org/10.1186/s12875-021-01602-w.
Dutch College of General Practitioners Guideline Development Group. Guideline cardiovascular risk management (second revision). Huisarts Wet. 2012;55:14–28.
Gude WT, Brown B, Van der Veer SN, Colquhoun HL, Ivers NM, Brehaut JC, Landis-Lewis Z, Armitage CJ, De Keizer NF, Peek N. Clinical performance comparators in audit and feedback: a review of theory and evidence. Implement Sci. 2019;14:39. https://doi.org/10.1186/s13012-019-0887-1.
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. https://doi.org/10.1136/bmj.b2393.
Van Son L, Vrijhoef VB, Crebolder H, Van Hoef L, Beusmans G. Support for the general practitioner. An exploration of the effect of the practice nurse on the care of asthma. COPD Diabetes Patients Huisarts Wet. 2004;47(1):15–21.
Yu EY, Wan EY, Wong CK, Chan AK, Chan KH, Ho SY, Kwok RL, Lam CL. Effects of risk assessment and management program for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study. J Hypertens. 2017;35(3):627–36. https://doi.org/10.1097/HJH.0000000000001177.
Wei X, Walley JD, Zhang Z, Zou G, Gong W, Deng S, Harries AD, Hicks JP, Chong MKC, Newell JN, Zhong J, Yu M. Implementation of a comprehensive intervention for patients at high risk of cardiovascular disease in rural China: A pragmatic cluster randomized controlled trial. PLoS One. 2017;12(8):e0183169. https://doi.org/10.1371/journal.pone.0183169.
Stephen C, Halcomb E, Fernandez R, McInnes S, Batterham M, Zwar N. Nurse-led interventions to manage hypertension in general practice: a systematic review and meta-analysis. J Adv Nurs. 2022;78(5):1281–93. https://doi.org/10.1111/jan.15159. Epub 2022 Mar 4.
van Bussel EF, Hoevenaar-Blom MP, Busschers WB, Richard E, Peters RJG, van Gool WA, Moll van Charante EP. Effects of Primary Cardiovascular Prevention on Vascular Risk in Older Adults. Am J Prev Med. 2018;55(3):368–75.
Marchal S, van 't Hof AW, Bilo HJ, Deijns SJ, Heeg JE, Schoenmakers M, Schouwink M, Schwantje O, Bots ML, Hoes AW, Hollander M. Integrated cardiovascular risk management program versus usual care in high CV risk patients: an observational study in general practice. BJGP Open. 2021;5(2):BJGPO.2020.0099. https://doi.org/10.3399/BJGPO.2020.0099.
Willems N, Romeijnders A, Smits G. Verminderen van praktijkvariatie in de eerste lijn. Huisarts Wet. 2017;60(11):580–3.
Bager JE, Mourtzinis G, Andersson T, Nåtman J, Rosengren A, Björck S, Manhem K, Hjerpe P. Trends in blood pressure, blood lipids, and smoking from 259753 patients with hypertension in a Swedish primary care register: results from QregPV. Eur J Prev Cardiol. 2022;29(1):158–66. https://doi.org/10.1093/eurjpc/zwab087.
Cholesterol Treatment Trialists’ (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized controlled trials. Lancet. 2012;380:581–90.
The Blood Pressure Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625–36.
Critchley JA, Capewell S: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003041. https://doi.org/10.1002/14651858.CD003041.pub2.
Ineen Transparante Ketenzorg Rapportage 2019 Zorggroepen Diabetes mellitus, VRM, COPD en Astma. Spiegel voor het verbeteren van chronische zorg, Juli 2020.